Group One Trading’s Immix Biopharma IMMX Stock Holding History

Group One Trading’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.06K	Hold	879	–	–	﹤0.01%	6457
2026 Q1	$8.01K	Buy	+879	New	+$6.46K	﹤0.01%	6484

Other funds holding IMMX

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's IMMX Position: Q2 2026 in Review

Group One Trading held its Immix Biopharma (IMMX) position steady in Q2 2026 at 879 shares worth $9.06K. The position accounts for ﹤0.01% of the portfolio, ranked #6457.

Group One Trading first reported a position in IMMX in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

Group One Trading held 879 shares of Immix Biopharma worth $9.06K as of Q2 2026.
Group One Trading left its Immix Biopharma share count unchanged in Q2 2026.
Immix Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6457 holding.
Group One Trading first reported a position in Immix Biopharma in Q1 2026 and has held it in 2 quarters since.
109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.